{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:46:50Z","timestamp":1782953210485,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Nanjing University of Traditional Chinese Medicine","award":["XZR2024069"],"award-info":[{"award-number":["XZR2024069"]}]},{"name":"the Basic Research Project of Medical Innovative Application in Suzhou","award":["SKYD2023071"],"award-info":[{"award-number":["SKYD2023071"]}]},{"name":"the Basic Research Program of Medical Application in Suzhou","award":["SKYD2023238"],"award-info":[{"award-number":["SKYD2023238"]}]},{"name":"Suzhou Applied Basic Research (Medical and Health) Youth Project","award":["SYWD2024188"],"award-info":[{"award-number":["SYWD2024188"]}]},{"name":"the Basic Research on Medical and Health Application in Taicang","award":["TC2024JCYL14"],"award-info":[{"award-number":["TC2024JCYL14"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82502879"],"award-info":[{"award-number":["82502879"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2025J08306"],"award-info":[{"award-number":["2025J08306"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Program of Xiamen Health Commission","award":["2024GZL-QN016"],"award-info":[{"award-number":["2024GZL-QN016"]}]},{"name":"the Special Project of Diagnosis and Treatment Technology for Key Clinical Diseases in Suzhou","award":["LCZX202302"],"award-info":[{"award-number":["LCZX202302"]}]},{"name":"the Key Project of \u201cStrengthening Health through Science and Education\u201d in Suzhou","award":["ZDXM2024001"],"award-info":[{"award-number":["ZDXM2024001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51480-4","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:16:09Z","timestamp":1777576569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hydroxysafflor yellow A attenuatesovariectomy induced bone loss andpromotes osteogenesis via PI3K\/AKT activation in an in vitro BMSC model"],"prefix":"10.1038","volume":"16","author":[{"given":"Mingzhou","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoran","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechun","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaozeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"21","key":"51480_CR1","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJMcp2307353","volume":"389","author":"MD Walker","year":"2023","unstructured":"Walker, M. D. & Shane, E. Osteoporosis. N. Engl. J. Med. 389 (21), 1979\u20131991 (2023).","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"51480_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ecl.2021.03.009","volume":"50","author":"RM Arceo-Mendoza","year":"2021","unstructured":"Arceo-Mendoza, R. M. & Camacho, P. M. Postmenopausal osteoporosis: Latest guidelines. Endocrinol. Metab. Clin. N. Am. 50 (2), 167\u2013178 (2021).","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"issue":"12","key":"51480_CR3","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1007\/s00198-023-06881-w","volume":"34","author":"A Barcelos","year":"2023","unstructured":"Barcelos, A., Goncalves, J., Mateus, C., Canhao, H. & Rodrigues, A. M. Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective. Osteoporos. Int. 34 (12), 2111\u20132119 (2023).","journal-title":"Osteoporos. Int."},{"issue":"3","key":"51480_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/jbmr.4773","volume":"38","author":"MM Weivoda","year":"2023","unstructured":"Weivoda, M. M. & Bradley, E. W. Macrophages and bone remodeling. J. Bone Min. Res. 38 (3), 359\u2013369 (2023).","journal-title":"J. Bone Min. Res."},{"issue":"1","key":"51480_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s11658-022-00371-3","volume":"27","author":"B Liang","year":"2022","unstructured":"Liang, B., Burley, G., Lin, S. & Shi, Y. C. Osteoporosis pathogenesis and treatment: Existing and emerging avenues. Cell. Mol. Biol. Lett. 27 (1), 72 (2022).","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"7","key":"51480_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41574-024-00969-x","volume":"20","author":"S Stegen","year":"2024","unstructured":"Stegen, S. & Carmeliet, G. Metabolic regulation of skeletal cell fate and function. Nat. Rev. Endocrinol. 20 (7), 399\u2013413 (2024).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"51480_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7326\/M22-0684","volume":"176","author":"C Ayers","year":"2023","unstructured":"Ayers, C. et al. Effectiveness and safety of treatments to prevent fractures in people with low bone mass or primary osteoporosis: A living systematic review and network meta-analysis for the American College of Physicians. Ann. Intern. Med. 176 (2), 182\u2013195 (2023).","journal-title":"Ann. Intern. Med."},{"issue":"10329","key":"51480_CR8","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","volume":"399","author":"IR Reid","year":"2022","unstructured":"Reid, I. R. & Billington, E. O. Drug therapy for osteoporosis in older adults. Lancet 399 (10329), 1080\u20131092 (2022).","journal-title":"Lancet"},{"key":"51480_CR9","doi-asserted-by":"publisher","first-page":"114669","DOI":"10.1016\/j.bcp.2021.114669","volume":"192","author":"T Chen","year":"2021","unstructured":"Chen, T., Wang, Y., Hao, Z., Hu, Y. & Li, J. Parathyroid hormone and its related peptides in bone metabolism. Biochem. Pharmacol. 192, 114669 (2021).","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"51480_CR10","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/jbmr\/zjae079","volume":"39","author":"JR Curtis","year":"2024","unstructured":"Curtis, J. R. et al. Comparative effectiveness of denosumab vs alendronate among postmenopausal women with osteoporosis. J. Bone Min. Res. 39 (7), 826\u2013834 (2024).","journal-title":"J. Bone Min. Res."},{"key":"51480_CR11","doi-asserted-by":"publisher","first-page":"101480","DOI":"10.1016\/j.molmet.2022.101480","volume":"60","author":"E Rendina-Ruedy","year":"2022","unstructured":"Rendina-Ruedy, E. & Rosen, C. J. Parathyroid hormone (PTH) regulation of metabolic homeostasis: An old dog teaches us new tricks. Mol. Metab. 60, 101480 (2022).","journal-title":"Mol. Metab."},{"issue":"4","key":"51480_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ecl.2024.08.002","volume":"53","author":"S Jain","year":"2024","unstructured":"Jain, S. Prevention and management of denosumab discontinuation rebound fractures. Endocrinol. Metab. Clin. N. Am. 53 (4), 559\u2013583 (2024).","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"51480_CR13","doi-asserted-by":"crossref","unstructured":"Aibar-Almazan, A., Voltes-Martinez, A., Castellote-Caballero, Y., Afanador-Restrepo, D. F. & Carcelen-Fraile, M. D. C. E. Lopez-Ruiz, Current status of the diagnosis and management of osteoporosis. Int. J. Mol. Sci. 23(16) (2022).","DOI":"10.3390\/ijms23169465"},{"issue":"2","key":"51480_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1210\/clinem\/dgad496","volume":"109","author":"SK Ramchand","year":"2024","unstructured":"Ramchand, S. K. & Leder, B. Z. Sequential therapy for the long-term treatment of postmenopausal osteoporosis. J. Clin. Endocrinol. Metab. 109 (2), 303\u2013311 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"51480_CR15","doi-asserted-by":"publisher","first-page":"579332","DOI":"10.3389\/fphar.2020.579332","volume":"11","author":"F Zhao","year":"2020","unstructured":"Zhao, F. et al. Hydroxysafflor yellow A: A systematical review on botanical resources, physicochemical properties, drug delivery system, pharmacokinetics, and pharmacological effects. Front. Pharmacol. 11, 579332 (2020).","journal-title":"Front. Pharmacol."},{"key":"51480_CR16","doi-asserted-by":"publisher","first-page":"153694","DOI":"10.1016\/j.phymed.2021.153694","volume":"91","author":"X Xue","year":"2021","unstructured":"Xue, X. et al. Hydroxysafflor yellow A, a natural compound from Carthamus tinctorius L. with good effect of alleviating atherosclerosis. Phytomedicine 91, 153694 (2021).","journal-title":"Phytomedicine"},{"key":"51480_CR17","doi-asserted-by":"publisher","first-page":"155814","DOI":"10.1016\/j.phymed.2024.155814","volume":"132","author":"W Wang","year":"2024","unstructured":"Wang, W. et al. Hydroxysafflor yellow A ameliorates alcohol-induced liver injury through PI3K\/Akt and STAT3\/NF-kappaB signaling pathways. Phytomedicine 132, 155814 (2024).","journal-title":"Phytomedicine"},{"key":"51480_CR18","doi-asserted-by":"publisher","first-page":"116268","DOI":"10.1016\/j.jep.2023.116268","volume":"308","author":"Z Lai","year":"2023","unstructured":"Lai, Z. et al. Hydroxysafflor yellow A confers neuroprotection against acute traumatic brain injury by modulating neuronal autophagy to inhibit NLRP3 inflammasomes. J. Ethnopharmacol. 308, 116268 (2023).","journal-title":"J. Ethnopharmacol."},{"key":"51480_CR19","doi-asserted-by":"publisher","first-page":"1495393","DOI":"10.3389\/fphar.2024.1495393","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Hydroxysafflor yellow A: A natural pigment with potential anticancer therapeutic effect. Front. Pharmacol. 15, 1495393 (2024).","journal-title":"Front. Pharmacol."},{"issue":"9","key":"51480_CR20","doi-asserted-by":"publisher","first-page":"e23797","DOI":"10.1002\/jbt.23797","volume":"38","author":"J Kuai","year":"2024","unstructured":"Kuai, J., Zheng, J., Kumar, A. & Gao, H. Anti-inflammatory, antiosteoporotic, and bone protective effect of hydroxysafflor yellow A against glucocorticoid-induced osteoporosis in rats. J. Biochem. Mol. Toxicol. 38 (9), e23797 (2024).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"51480_CR21","doi-asserted-by":"publisher","first-page":"106033","DOI":"10.1016\/j.biocel.2021.106033","volume":"137","author":"P Wang","year":"2021","unstructured":"Wang, P. et al. Hydroxysafflor yellow A promotes osteogenesis and bone development via epigenetically regulating beta-catenin and prevents ovariectomy-induced bone loss. Int. J. Biochem. Cell. Biol. 137, 106033 (2021).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"51480_CR22","doi-asserted-by":"publisher","first-page":"117109","DOI":"10.1016\/j.taap.2024.117109","volume":"492","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y., Wang, R., Li, A., Zhao, P. & Yang, J. Protective effect of hydroxysafflor yellow a on thioacetamide-induced liver injury and osteopenia in zebrafish. Toxicol. Appl. Pharmacol. 492, 117109 (2024).","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"D1","key":"51480_CR23","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"51480_CR24","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"1","key":"51480_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"18","key":"51480_CR26","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s40265-017-0838-6","volume":"77","author":"A Markham","year":"2017","unstructured":"Markham, A. Copanlisib: First global approval. Drugs 77 (18), 2057\u20132062 (2017).","journal-title":"Drugs"},{"issue":"9","key":"51480_CR27","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41574-023-00866-9","volume":"19","author":"I Foessl","year":"2023","unstructured":"Foessl, I., Dimai, H. P. & Obermayer-Pietsch, B. Long-term and sequential treatment for osteoporosis. Nat. Rev. Endocrinol. 19 (9), 520\u2013533 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"51480_CR28","doi-asserted-by":"crossref","unstructured":"Qaseem, A. et al. Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: A living clinical guideline from the American College of Physicians. Ann. Intern. Med. 176(2), 224\u2013238 (2023).","DOI":"10.7326\/M22-1034"},{"issue":"2","key":"51480_CR29","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/endrev\/bnab028","volume":"43","author":"PR Ebeling","year":"2022","unstructured":"Ebeling, P. R. et al. Secondary osteoporos. Endocr. Rev. 43(2) 240\u2013313. (2022).","journal-title":"Endocr. Rev."},{"issue":"4","key":"51480_CR30","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ecl.2024.08.008","volume":"53","author":"P Subarajan","year":"2024","unstructured":"Subarajan, P., Arceo-Mendoza, R. M. & Camacho, P. M. Postmenopausal osteoporosis: A review of latest guidelines. Endocrinol. Metab. Clin. N. Am. 53 (4), 497\u2013512 (2024).","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"issue":"1","key":"51480_CR31","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC202401160","volume":"177","author":"KE Ensrud","year":"2024","unstructured":"Ensrud, K. E. & Crandall, C. J. Osteoporosis. Ann. Intern. Med. 177(1), ITC1\u2013ITC16 (2024).","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"51480_CR32","doi-asserted-by":"publisher","first-page":"e31484","DOI":"10.1002\/jcp.31484","volume":"240","author":"YF Fu","year":"2025","unstructured":"Fu, Y. F. et al. Osteoclast secretes stage-specific key molecules for modulating osteoclast-osteoblast communication. J. Cell. Physiol. 240 (1), e31484 (2025).","journal-title":"J. Cell. Physiol."},{"key":"51480_CR33","doi-asserted-by":"crossref","unstructured":"Lee, S. et al. Exploring the anti-osteoporotic potential of daucosterol: impact on osteoclast and osteoblast activities. Int. J. Mol. Sci. 24(22) (2023).","DOI":"10.3390\/ijms242216465"},{"key":"51480_CR34","doi-asserted-by":"publisher","first-page":"155501","DOI":"10.1016\/j.phymed.2024.155501","volume":"128","author":"H Xu","year":"2024","unstructured":"Xu, H. et al. Jiangu formula: A novel osteoclast-osteoblast coupling agent for effective osteoporosis treatment. Phytomedicine 128, 155501 (2024).","journal-title":"Phytomedicine"},{"key":"51480_CR35","doi-asserted-by":"crossref","unstructured":"Kim, J. M., Lin, C., Stavre, Z., Greenblatt, M. B. & Shim, J. H. Osteoblast-osteoclast communication bone homeost. Cells 9(9) (2020).","DOI":"10.3390\/cells9092073"},{"key":"51480_CR36","doi-asserted-by":"crossref","unstructured":"McDonald, M. M. et al. Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption. Cell 184(5), 1330\u20131347 e13 (2021).","DOI":"10.1016\/j.cell.2021.02.002"},{"issue":"1","key":"51480_CR37","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s13018-025-05697-0","volume":"20","author":"W Ji","year":"2025","unstructured":"Ji, W. et al. Icariin promotes osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) by activating PI3K-AKT-UTX\/EZH2 signaling in steroid-induced femoral head osteonecrosis. J. Orthop. Surg. Res. 20 (1), 290 (2025).","journal-title":"J. Orthop. Surg. Res."},{"issue":"3","key":"51480_CR38","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11914-024-00868-0","volume":"22","author":"Y Feng","year":"2024","unstructured":"Feng, Y. et al. Quercetin in osteoporosis treatment: A comprehensive review of its mechanisms and therapeutic potential. Curr. Osteoporos. Rep. 22 (3), 353\u2013365 (2024).","journal-title":"Curr. Osteoporos. Rep."},{"issue":"1","key":"51480_CR39","doi-asserted-by":"publisher","first-page":"14047","DOI":"10.1038\/s41598-024-64952-2","volume":"14","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Exploring the effects of naringin on oxidative stress-impaired osteogenic differentiation via the Wnt\/\u03b2-catenin and PI3K\/Akt pathways. Sci. Rep. 14 (1), 14047 (2024).","journal-title":"Sci. Rep."},{"issue":"2","key":"51480_CR40","doi-asserted-by":"publisher","first-page":"166977","DOI":"10.1016\/j.bbadis.2023.166977","volume":"1870","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Isoquercitrin attenuates the osteoclast-mediated bone loss in rheumatoid arthritis via the Nrf2\/ROS\/NF-\u03baB pathway. Biochim. Biophys. Acta Mol. Basis Dis. 1870 (2), 166977 (2024).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"6","key":"51480_CR41","first-page":"6330","volume":"13","author":"X Ge","year":"2021","unstructured":"Ge, X. & Zhou, G. Protective effects of naringin on glucocorticoid-induced osteoporosis through regulating the PI3K\/Akt\/mTOR signaling pathway. Am. J. Transl. Res. 13 (6), 6330\u20136341 (2021).","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"51480_CR42","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11914-012-0109-0","volume":"10","author":"PJ Marie","year":"2012","unstructured":"Marie, P. J. Signaling pathways affecting skeletal health. Curr. Osteoporos. Rep. 10 (3), 190\u2013198 (2012).","journal-title":"Curr. Osteoporos. Rep."},{"issue":"1","key":"51480_CR43","doi-asserted-by":"publisher","first-page":"112137","DOI":"10.1016\/j.yexcr.2020.112137","volume":"394","author":"J Dong","year":"2020","unstructured":"Dong, J., Xu, X., Zhang, Q., Yuan, Z. & Tan, B. The PI3K\/AKT pathway promotes fracture healing through its crosstalk with Wnt\/beta-catenin. Exp. Cell. Res. 394 (1), 112137 (2020).","journal-title":"Exp. Cell. Res."},{"issue":"1","key":"51480_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1083\/jcb.200401138","volume":"166","author":"T Fujita","year":"2004","unstructured":"Fujita, T. et al. Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J. Cell. Biol. 166 (1), 85\u201395 (2004).","journal-title":"J. Cell. Biol."},{"issue":"8","key":"51480_CR45","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/cbin.10779","volume":"41","author":"Y Chen","year":"2017","unstructured":"Chen, Y. et al. Runx2 alleviates high glucose-suppressed osteogenic differentiation via PI3K\/AKT\/GSK3beta\/beta-catenin pathway. Cell. Biol. Int. 41 (8), 822\u2013832 (2017).","journal-title":"Cell. Biol. Int."},{"key":"51480_CR46","doi-asserted-by":"crossref","unstructured":"Komori, T. Regulation of proliferation, differentiation and functions of osteoblasts by Runx2. Int. J. Mol. Sci. 20(7) (2019).","DOI":"10.3390\/ijms20071694"},{"key":"51480_CR47","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ijbiomac.2015.04.008","volume":"78","author":"S Vimalraj","year":"2015","unstructured":"Vimalraj, S., Arumugam, B., Miranda, P. J. & Selvamurugan, N. Runx2: Structure, function, and phosphorylation in osteoblast differentiation. Int. J. Biol. Macromol. 78, 202\u2013208 (2015).","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"51480_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41421-024-00689-6","volume":"10","author":"S Zhu","year":"2024","unstructured":"Zhu, S., Chen, W., Masson, A. & Li, Y. P. Cell signaling and transcriptional regulation of osteoblast lineage commitment, differentiation, bone formation, and homeostasis. Cell. Discov. 10 (1), 71 (2024).","journal-title":"Cell. Discov."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51480-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51480-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51480-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:07:40Z","timestamp":1782950860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51480-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51480"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51480-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal study was reviewed and approved by the Ethics Committee of Taicang TCM Hospital Affiliated to Nanjing University of Chinese Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"20196"}}